Sector News

UnitedHealth adds new C-suite member from Lockheed Martin

November 14, 2019
Life sciences

UnitedHealth Group Inc. has hired Patricia Lewis as its new chief human resources officer. She’ll serve in the office of the chief executive, the company said in an email. She’s replacing D. Ellen Wilson, who is retiring.

Previously, Lewis served in the same role at Lockheed Martin Corp. She’s also worked in human resources for IBM and DuPont.

At Lockheed Martin, Lewis had success starting a number of talent initiatives, including the STEM Scholarship Program and the Program Management Talent Initiative, with the goal of increasing the presence of traditionally underrepresented groups in STEM.

Lewis was recently featured in Politco’s “Women Rule” newsletter under the heading “Wisdom of the Week.” Her wisdom read, in part, “Bold leaders consistently demonstrate courage. Being courageous means taking risks even if you are faced with an uncertain outcome.”

UnitedHealth is Minnesota’s largest public company. In 2018, it had an income of $11.99 billion on $229.48 billion in sales. It employs 18,500 people in Minnesota alone, according to Business Journal research.

By: Carrigan Miller

Source: bizjournals.com

Join the discussion!

Your email address will not be published. Required fields are marked *

Related News

January 10, 2021

Merck to acquire German contract development company AmpTec

Life sciences

The deal will enhance Merck’s expertise in developing and manufacturing mRNA for its customers for use in vaccines, treatments and diagnostics applicable in Covid-19 and various other diseases.

January 10, 2021

Goodbye pill, hello science: Pfizer debuts redesigned logo with double helix

Life sciences

It’s the first significant visual redesign for Pfizer in 70 years since the company began using the blue oval background. The tagline outlining Pfizer’s purpose, “Breakthroughs that change patients’ lives,” remains the same.

January 10, 2021

Fujifilm triples down on viral vector manufacturing with new $40M Boston site

Life sciences

The massive growth of gene therapy research and development over the last few years has boosted demand for viral vectors, the engineered viruses used to deliver therapeutic genes into patients’ bodies. Tokyo-based Fujifilm Diosynth Biotechnologies is stepping up to meet that demand.

Send this to a friend